Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome

Ashraf F HannaDepartment of Pain Management, Florida Spine Institute, Clearwater, FL, USACorrespondence[email protected]

Bishoy AbrahamDepartment of Pain Management, Florida Spine Institute, Clearwater, FL, USA

Andrew HannaDepartment of Pain Management, Florida Spine Institute, Clearwater, FL, USA

Adam J SmithDepartment of Pain Management, Florida Spine Institute, Clearwater, FL, USA

Pages 305-308 | Published online: 18 Aug 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SinnerBGrafBMKetamineHandb Exp Pharmacol200818231333318175098
PubMedGoogle Scholar
U.S. National Institutes of Health [homepage on the Internet] Available from: https://clinicaltrials.gov/Accessed May 22, 2016
Google Scholar
LooCKGalvezVO’KeefeEPlacebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depressionActa Psychiatr Scand20161341485627028832
PubMed Web of Science ®Google Scholar
HuYDXiangYTFangJXSingle i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week studyPsychol Med201646362363526478208
PubMed Web of Science ®Google Scholar
PriceRBIosifescuDVMurroughJWEffects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depressionDepress Anxiety201431433534324668760
PubMed Web of Science ®Google Scholar
MiziaraLESimoniRFEstevesLOCangianiLHGrillo-FilhoGFPaulaAGEfficacy of continuous S(+)-ketamine infusion for postoperative pain control: a randomized placebo-controlled trialAnesthesiol Res Pract20162016691832726949390
PubMedGoogle Scholar
LoixSDe KockMHeninPThe anti-inflammatory effects of ketamine: state of the artActa Anaesthesiol Belg2011621475821612145
PubMedGoogle Scholar
ZilbersteinGLevyRRachinskyMKetamine attenuates neutrophil activation after cardiopulmonary bypassAnesth Analg2002953531536 table of contents12198030
PubMed Web of Science ®Google Scholar
SorensenJBengtssonABackmanEHenrikssonKGBengtssonMPain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamineScand J Rheumatol19952463603658610220
PubMed Web of Science ®Google Scholar
TakahashiHMiyazakiMNanbuTYanagidaHMoritaSThe NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical casePain1998752–33913949583776
PubMed Web of Science ®Google Scholar
OlsenYThe CDC guideline on opioid prescribing: rising to the challengeJAMA2016315151577157926978227
PubMed Web of Science ®Google Scholar
AucottJNCrowderLAKortteKBDevelopment of a foundation for a case definition of post-treatment Lyme disease syndromeInt J Infect Dis2013176e443e44923462300
PubMed Web of Science ®Google Scholar
BockenstedtLKGonzalezDGHabermanAMBelperronAASpirochete antigens persist near cartilage after murine Lyme borreliosis therapyJ Clin Invest201212272652266022728937
PubMed Web of Science ®Google Scholar
SteereACDurayPHButcherECSpirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissueArthritis Rheum19883144874953258751
PubMed Web of Science ®Google Scholar
SinghJBFedgchinMDalyEJA double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depressionAm J Psychiatry2016173881682627056608
PubMed Web of Science ®Google Scholar
LiCTChenMHLinWCThe effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: a randomized controlled studyHum Brain Mapp20163731080109026821769
PubMed Web of Science ®Google Scholar
GalvezVO’KeefeECotigaLLong-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case reportBiol Psychiatry2014763e1e224507509
PubMed Web of Science ®Google Scholar
ClarkPTreatment-refractory depression: a case of successful treatment with intranasal ketamine 10%Ann Clin Psychiatry201426214524501735
PubMed Web of Science ®Google Scholar
HannaAFSmithAJIntravenous ketamine produces long-term pain relief in a patient with fibromyalgiaFibromyalgia201611104
Google Scholar
HannaAFArmstrongJSSmithAJEffects of intravenous ketamine infusions in a neuropathic pain patient with lichen sclerosus et atrophicusCase Rep Dermatol20168216417027462225
PubMedGoogle Scholar
SchwartzmanRJAlexanderGMGrothusenJRPaylorTReichenbergerEPerreaultMOutpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled studyPain20091471–310711519783371
PubMed Web of Science ®Google Scholar
KieferRTRohrPPloppaAAltemeyerKHSchwartzmanRJComplete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolamPain Pract20077214715017559485
PubMedGoogle Scholar
WieberJGuglerRHengstmannJHDenglerHJPharmacokinetics of ketamine in manAnaesthesist19752462602631155748
PubMed Web of Science ®Google Scholar
ClementsJANimmoWSPharmacokinetics and analgesic effect of ketamine in manBr J Anaesth198153127307459184
PubMed Web of Science ®Google Scholar
WeissenbacherSRingJHofmannHGabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage Lyme borreliosis: a pilot studyDermatology2005211212312716088158
PubMed Web of Science ®Google Scholar
WoolfCJCentral sensitization: implications for the diagnosis and treatment of painPain20111523 supplS2S1520961685
PubMed Web of Science ®Google Scholar
PerssonJAxelssonGHallinRGGustafssonLLBeneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitizationPain19956022172227784107
PubMed Web of Science ®Google Scholar
HayashiYKawajiKSunLMicroglial Ca(2+)-activated K(+) channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic painJ Neurosci20113148173701738222131399
PubMed Web of Science ®Google Scholar
WilkersonRGKimHKWindsorTAMareinissDPThe opioid epidemic in the United StatesEmerg Med Clin North Am2016342e1e2327133253
PubMedGoogle Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effects of intravenous ketamine in a patient with post-treatment Lyme disease syndrome

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date